Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Teclison | Transforming cancer treatment by enhancing |
Description | At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better |
Keywords | N/A |
WebSite | teclison.com |
Host IP | 76.76.21.21 |
Location | United States |
Site | Rank |
US$1,988,685
Last updated: 2023-05-08 08:13:05
teclison.com has Semrush global rank of 5,322,264. teclison.com has an estimated worth of US$ 1,988,685, based on its estimated Ads revenue. teclison.com receives approximately 229,464 unique visitors each day. Its web server is located in United States, with IP address 76.76.21.21. According to SiteAdvisor, teclison.com is safe to visit. |
Purchase/Sale Value | US$1,988,685 |
Daily Ads Revenue | US$1,836 |
Monthly Ads Revenue | US$55,072 |
Yearly Ads Revenue | US$660,856 |
Daily Unique Visitors | 15,298 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
teclison.com. | A | 10800 | IP: 76.76.21.21 |
teclison.com. | NS | 3600 | NS Record: ns09.domaincontrol.com. |
teclison.com. | NS | 3600 | NS Record: ns10.domaincontrol.com. |
teclison.com. | MX | 3600 | MX Record: 0 teclison-com.mail.protection.outlook.com. |
teclison.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
About Us Our Approach Pipeline Contact In the News Main Menu Transforming cancer treatment by enhancing immunotherapy We develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering cancer patients the hope of longer, better lives. About Us Our Approach Our innovative platform radically remodels the tumor immune microenvironment of solid cancers, unlocking the ability to successfully treat cancer patients who respond poorly to existing immunotherapies. Our Approach Our Pipeline Our innovative approaches aim to enhance immune checkpoint inhibitors (ICIs) and prolong the lives of patients with solid tumor cancers that have metastasized to the liver. Our Pipeline “We believe in our pipeline’s ability to enhance and achieve long-term remission for patients” “We believe in our pipeline’s ability to enhance and achieve long-term remission for patients” Careers Every day, we are exploring new ways to improve the lives of patients with solid tumor |
HTTP/1.1 308 Permanent Redirect Date: Fri, 29 Oct 2021 16:22:27 GMT Content-Type: text/plain Connection: keep-alive Location: https://teclison.com/ Refresh: 0;url=https://teclison.com/ server: Vercel x-vercel-id: iad1::q8bh9-1635524547430-2e2944e9f6be HTTP/2 200 date: Fri, 29 Oct 2021 16:22:27 GMT content-type: text/html; charset=utf-8 content-length: 8570 content-disposition: inline; filename="index" cache-control: public, max-age=0, must-revalidate etag: W/"dea5922e88ca0f98901f397106516c61e2085b86b9e8eb5499d2aaea44da2653" access-control-allow-origin: * accept-ranges: bytes age: 1323339 x-vercel-cache: HIT server: Vercel x-vercel-id: cle1:cle1::9szth-1635524547495-750cf622db97 strict-transport-security: max-age=63072000 |
Domain Name: TECLISON.COM Registry Domain ID: 1840002854_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-12-22T18:12:55Z Creation Date: 2013-12-22T03:17:41Z Registry Expiry Date: 2021-12-22T03:17:41Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS09.DOMAINCONTROL.COM Name Server: NS10.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T05:10:25Z <<< |